Results 131 to 140 of about 6,214,933 (159)
Some of the next articles are maybe not open access.

CLN2 Disease: Current Understandings, Challenges, and Future Directions

Journal of Child Neurology
Neuronal ceroid lipofuscinosis type 2 (CLN2) disease is a rare neurodegenerative condition that rapidly progresses with language regression, loss of ambulation, blindness, intractable seizures, and premature death in childhood. Enzyme replacement therapy has transformed the clinical trajectory of CLN2 disease, and early genetic testing is crucial ...
Maria Shock   +3 more
openaire   +2 more sources

PD49 Social Preferences In HTA: A Pilot Analysis In CLN2 Disease

International Journal of Technology Assessment in Health Care, 2018
Introduction:It is established that the current cost effectiveness health technology assessment (HTA) paradigm does not appropriately value rare disease technologies. Social willingness-to-pay (SWTP) has been suggested to be higher for rare disease technologies, it's inclusion into existing HTA framework could better reflect social preferences (SP) and
Sumeet Bakshi   +7 more
openaire   +1 more source

CLN2 Disease (Classic Late Infantile Neuronal Ceroid Lipofuscinosis).

Pediatric endocrinology reviews : PER, 2016
CLN2 disease is an inherited metabolic storage disorder caused by the deficiency of the lysosomal enzyme tripeptidyl peptidase 1 (TPP1). The disease affects mainly the brain and the retina and is characterized by progressive dysfunction of the central nervous system, leading to dementia, epilepsy, loss of motor function and blindness.
Alfried, Kohlschütter, Angela, Schulz
openaire   +1 more source

Intrafamilial variability in late-onset CLN2 disease

Molecular Genetics and Metabolism, 2020
Sharan Goobie   +2 more
openaire   +1 more source

LINCE project: A fast diagnosis of CLN2 disease

Molecular Genetics and Metabolism, 2020
Pablo Crujeiras   +4 more
openaire   +1 more source

Possibilities for an early diagnosis of CLN2-disease

Molecular Genetics and Metabolism, 2016
Simona Murko   +5 more
openaire   +1 more source

Expert opinion on the management of CLN2 disease

Molecular Genetics and Metabolism, 2016
TOPÇU, MERAL   +24 more
openaire   +2 more sources

Loss of visual function associated with photoreceptor degeneration in CLN2 disease

Molecular Genetics and Metabolism, 2023
Christina Ohnsman   +6 more
openaire   +1 more source

Home - About - Disclaimer - Privacy